
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
The latest news for pharma industry insiders.
Drug shortages, including critical antibiotics, fever medications, and cancer treatments, highlight global supply chain issues and the need for improved health policies to prevent medication bottlenecks.
The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the psychedelics vying for FDA approval: psilocybin for treatment resistant depression.
Companion apps promise to keep you company. We decided to put them to the test.
Advanced Clinical, a privately-held clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to share that we’ve been named one of Crain’s Best Places to Work in Chicago 2024.
I'm excited to share a new thought leadership article I wrote in partnership with Yakir Siega land Gregory Lief! I'm beyond thrilled to see it published in Pharmaceutical Executive magazine where it will reach a broad range of leaders in the industry. My deep gratitude goes out to Yakir and Greg for believing in this piece and empowering me to share my research and perspectives.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

